Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
CollPlant Biotechnologies Ltd. (NASDAQ: CLGN)
CLGN Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
27.60%
Analyst Rating:
BUY
Analyst Forecast (1yr):
400%
CLGN Stock Analysis
CLGN
PE Ratio:
CLGN
PEG Ratio:
Not Available
CLGN
Forward EPS Growth (12 month):
0.00%
CLGN
PS Ratio:
12.9
CLGN
PSG Ratio:
0.3
CLGN
Forward Revenue Growth (12 month):
38.00%
CLGN Articles
No data was found